202 related articles for article (PubMed ID: 31965937)
1. Is Technical-Grade Chlordane an Obesogen?
Silva JF; Moreira BP; Rato L; de Lourdes Pereira M; Oliveira PF; Alves MG
Curr Med Chem; 2021; 28(3):548-568. PubMed ID: 31965937
[TBL] [Abstract][Full Text] [Related]
2. The fate of technical-grade chlordane in mice fed a high-fat diet and its roles as a candidate obesogen.
Wang D; Wang X; Zhang P; Wang Y; Zhang R; Yan J; Zhou Z; Zhu W
Environ Pollut; 2017 Mar; 222():532-542. PubMed ID: 28041837
[TBL] [Abstract][Full Text] [Related]
3. Technical-grade chlordane compromises rat Sertoli cells proliferation, viability and metabolic activity.
Moreira BP; Silva JF; Jarak I; de Lourdes Pereira M; Oliveira PF; Alves MG
Toxicol In Vitro; 2020 Mar; 63():104673. PubMed ID: 31704469
[TBL] [Abstract][Full Text] [Related]
4. Endocrine Disruptors and Obesity.
Darbre PD
Curr Obes Rep; 2017 Mar; 6(1):18-27. PubMed ID: 28205155
[TBL] [Abstract][Full Text] [Related]
5. Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop.
Heindel JJ; Alvarez JA; Atlas E; Cave MC; Chatzi VL; Collier D; Corkey B; Fischer D; Goran MI; Howard S; Kahan S; Kayhoe M; Koliwad S; Kotz CM; La Merrill M; Lobstein T; Lumeng C; Ludwig DS; Lustig RH; Myers P; Nadal A; Trasande L; Redman LM; Rodeheffer MS; Sargis RM; Stephens JM; Ziegler TR; Blumberg B
Am J Clin Nutr; 2023 Jul; 118(1):329-337. PubMed ID: 37230178
[TBL] [Abstract][Full Text] [Related]
6. Role of Obesogens in the Pathogenesis of Obesity.
Shahnazaryan U; Wójcik M; Bednarczuk T; Kuryłowicz A
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438630
[TBL] [Abstract][Full Text] [Related]
7. Obesogens.
Grün F
Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):453-9. PubMed ID: 20689419
[TBL] [Abstract][Full Text] [Related]
8. Obesity II: Establishing causal links between chemical exposures and obesity.
Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
[TBL] [Abstract][Full Text] [Related]
9. Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.
Mohajer N; Du CY; Checkcinco C; Blumberg B
Front Endocrinol (Lausanne); 2021; 12():780888. PubMed ID: 34899613
[TBL] [Abstract][Full Text] [Related]
10. Obesogens and male fertility.
Cardoso AM; Alves MG; Mathur PP; Oliveira PF; Cavaco JE; Rato L
Obes Rev; 2017 Jan; 18(1):109-125. PubMed ID: 27776203
[TBL] [Abstract][Full Text] [Related]
11. Obesogenic endocrine disruptors and obesity: myths and truths.
Muscogiuri G; Barrea L; Laudisio D; Savastano S; Colao A
Arch Toxicol; 2017 Nov; 91(11):3469-3475. PubMed ID: 28975368
[TBL] [Abstract][Full Text] [Related]
12. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
Grün F; Blumberg B
Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
[TBL] [Abstract][Full Text] [Related]
13. trans-Nonachlor and cis-nonachlor toxicity in Sprague-Dawley rats: comparison with technical chlordane.
Bondy GS; Newsome WH; Armstrong CL; Suzuki CA; Doucet J; Fernie S; Hierlihy SL; Feeley MM; Barker MG
Toxicol Sci; 2000 Dec; 58(2):386-98. PubMed ID: 11099650
[TBL] [Abstract][Full Text] [Related]
14. Environmental Obesogens: Mechanisms and Controversies.
Heindel JJ; Blumberg B
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():89-106. PubMed ID: 30044726
[TBL] [Abstract][Full Text] [Related]
15. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity.
Janesick A; Blumberg B
Birth Defects Res C Embryo Today; 2011 Mar; 93(1):34-50. PubMed ID: 21425440
[TBL] [Abstract][Full Text] [Related]
16. Transgenerational inheritance of prenatal obesogen exposure.
Janesick AS; Shioda T; Blumberg B
Mol Cell Endocrinol; 2014 Dec; 398(1-2):31-5. PubMed ID: 25218215
[TBL] [Abstract][Full Text] [Related]
17. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.
Chen JQ; Brown TR; Russo J
Biochim Biophys Acta; 2009 Jul; 1793(7):1128-43. PubMed ID: 19348861
[TBL] [Abstract][Full Text] [Related]
18. ENDOCRINE DISRUPTING CHEMICALS AND OBESITY: THE EVOLVING STORY OF OBESOGENS.
Micić D; Polovina S; Micić D; Macut D
Acta Endocrinol (Buchar); 2021; 17(4):503-508. PubMed ID: 35747866
[TBL] [Abstract][Full Text] [Related]
19. Obesogens: an emerging threat to public health.
Janesick AS; Blumberg B
Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
[TBL] [Abstract][Full Text] [Related]
20. Obesogens, stem cells and the developmental programming of obesity.
Janesick A; Blumberg B
Int J Androl; 2012 Jun; 35(3):437-48. PubMed ID: 22372658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
